NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
12.74
-0.04 (-0.31%)
Nov 7, 2025, 11:04 AM EST - Market open
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $424.34 million as of November 7, 2025. Its market cap has increased by 134.41% in one year.
Market Cap
424.34M
Enterprise Value
439.00M
1-Year Change
134.41%
Ranking
Category
Stock Price
$12.74
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $424.34M, an increase of 7.90%. That is a compound annual growth rate of 1.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 432.33M | 29.44% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 838.83B |
| Johnson & Johnson | 448.51B |
| AbbVie | 382.59B |
| UnitedHealth Group | 295.89B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.18B |
| Thermo Fisher Scientific | 213.04B |